Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-347-5 | CAS number: 94-60-0
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 20.57 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 24
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.87 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 24
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
Workers
Chapter 8 of the reach TGD (Appendix R.8 -8) indicates that acute exposure DNEL values are not normally required. Additionally, the lack of acute oral or dermal toxicity for a principal metabolite (1,4 -cyclohexane dicarboxylic acid; CHDA) would indicate that DMCD is non-hazardous under acute exposure scenarios. It is assumed also that there will be no acute or ling-term oral exposures to DMCD in worker populations. Eye and respiratory irritation thresholds are assumed to exceed thresholds for chronic systemic effects.
Long-term inhalation, systemic
A 14 -week repeat dose oral toxicity study using CHDA gave a NOEL of 100 mg/kg. Using CHDA data to read-across to DMCD, and extrapolating from subchronic oral toxicity to chronic inhalation, the NOEL first must be converted to mg/m3 by dividing by a factor of 0.38, and then corrected for oral bioavailability (50%) by multiplying by a factor of 2. Further corrections are then necessary to convert from the 6 hour daily exposure to an 8 hour per day exposure (0.75), correction for 7-day experimental exposure to 5-day work week (1.4) and to adjusted for respiration for light work (0.67). ECETOC Assessment factors were applied, which consisted of subchronic to chronic studies (2), for intraspecies (3), for interspecies (4), for a total of 24.
- Converting mg/kg to mg/m3 = 100/0.38 = 263.16 mg/m3
- Correcting for oral bioavailability = 263.16*2 = 526.32 mg/m3
- Correcting for 7-day experimental exposure to 5-day work week, and light work= 526.32 mg/m3* (1.4) *(0.67) = 493.69 mg/m3
- Application of adjustment factors: 493.69 mg/m3/24 =20.57 mg/m3
Long-term dermal, systemic
A 14 -week repeat dose oral toxicity study using CHDA gave a NOEL of 100 mg/kg. Using CHDA data to read-across to DMCD, and extrapolating from subchronic oral toxicity to chronic dermal, theNOEL first must be corrected to convert from the 6 hour daily exposure to an 8 hour per day exposure (0.75), and correction for 7-day experimental exposure to 5-day work week (1.4) and to adjusted for respiration for light work (0.67). ECETOC Assessment factors were applied, which consisted of subchronic to chronic studies (2), for intraspecies (3), for interspecies (4), for a total of 24.
- Correcting for 7-day experimental exposure to 5-day work week, and light work = 100 mg/kg*(1.4)*(0.67) = 92.96 mg/kg
- Application of adjustment factors: 92.96 mg/kg/24 = 3.87 mg/kg
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.35 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 40
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 40
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 40
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
General Population
Chapter 8 of the reach TGD (Appendix R.8 -8) indicates that acute exposure DNEL values are not normally required. Additionally, the lack of acute oral or dermal toxicity for a principal metabolite (1,4 -cyclohexane dicarboxylic acid; CHDA) would indicate that DMCD is non-hazardous under acute exposure scenarios. It is assumed also that there will be no acute oral exposures to DMCD in general populations. Eye and respiratory irritation thresholds are assumed to exceed thresholds for chronic systemic effects.
Long-term inhalation, systemic
A 14 -week repeat dose oral toxicity study using CHDA gave a NOEL of 100 mg/kg. Using these data to read-across to DMCD, and extrapolating from subchronic oral toxicity to chronic inhalation, theNOEL first must be converted to mg/m3by dividing by a factor of 1.15, and then corrected for oral bioavailability (50%) by multiplying by a factor of 2. ECETOC Assessment factors were applied, which consisted of subchronic to chronic studies (2), for intraspecies (5), for interspecies (4), for a total of 40.
- Converting mg/kg to mg/m3= 100/1.15 = 86.96 mg/m3
- Correcting for oral bioavailability = 86.96*2 = 173.91 mg/m3
- Application of adjustment factors – 173.91 mg/m3/40 = 4.35 mg/m3
Long-term dermal, systemic
A 14 -week repeat dose oral toxicity study using CHDA gave a NOEL of 100 mg/kg. These data were used to read-across to DMCD. ECETOC Assessment factors were applied, which consisted of subchronic to chronic studies (2), for intraspecies (5), for interspecies (4), for a total of 40.
- Application of adjustment factors: 100 mg/kg/40 = 2.50 mg/kg
Long-term oral, systemic
A 14 -week repeat dose oral toxicity study using CHDA gave a NOEL of 100 mg/kg. These data were used to read-across to DMCD. ECETOC Assessment factors were applied, which consisted of subchronic to chronic studies (2), for intraspecies (5), for interspecies (4), for a total of 40.
- Application of adjustment factors: 100 mg/kg/40 = 2.50 mg/kg
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
